全球带状疱疹疫苗市场（2023-2030）：按产品类型（Shingrix/Zostavax）/疫苗类型（重组疫苗/减毒疫苗）分類的规模、份额、增长分析和预测

全球带状疱疹疫苗市场规模预计将从2021年的35亿美元增长到2022年的39.9亿美元，预测期内年复合成长率为7.6%，到2030年将达到112.9亿美元。

全球带状疱疹疫苗市场受到多种要素的推动，例如人口高龄化、人们对疫苗预防带状疱疹及相关合併的有效性的认识不断提高以及各地区疫苗接种计划的扩大等，预计未来几年将出现强劲增长。市场对减毒活病毒疫苗和重组亚单位疫苗的需求稳定增长，后者因其安全性而受到青睐。此外，持续进行的旨在提高疫苗功效和可及性的研发，加上政府促进成人疫苗接种的努力，预计将刺激市场扩张。製药行业的主要企业预计将专注于技术创新和战略联盟，以利用这一不断扩大的市场机会。

全球带状疱疹疫苗市场的主要趋势之一是日益关注人口高龄化的预防性医疗保健和免疫计划。各国政府和医疗机构积极推动带状疱疹疫苗接种活动，疫苗接种率不断提高。此外，疫苗技术的进步，例如开发更有效、更持久的疫苗，预计也将进一步推动市场增长。

本报告调查了全球带状疱疹疫苗市场，并提供了市场概况、影响市场的各种因素分析、技术和创新趋势、法律和法规环境、市场规模趋势和预测，以及按各个细分市场和地区进行的细分。我们总结了主要企业的细分、竞争形势和概况。

目录

• 执行摘要
• 调查方法
• 母市场分析
  • 市场概况
  • 市场规模
  • 市场动态
• 关键市场洞察
  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 知识产权分析
  • 贸易分析
  • 启动分析
  • 原材料分析
  • 创新矩阵
  • 管道产品分析
  • 宏观经济指标
  • 重点投资分析
  • 关键成功要素
  • 竞争程度
• 市场动态及预测
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 课题
• 法规状况
• 波特的分析
• Skyquest 对未来颠覆的独家见解
• 全球带状疱疹疫苗市场：副产品
  • 市场概况
  • Shingrix
  • Zostavax
  • SKYZoster
• 全球带状疱疹疫苗市场：按疫苗类型
  • 市场概况
  • 重组疫苗
  • 减毒活疫苗
• 全球带状疱疹疫苗市场：按地区
  • 市场概况
  • 北美
  • 欧洲
  • 亚太地区
  • 拉美
  • 中东/非洲
• 竞争形势
  • 前5名企业对比
  • 主要企业市场地位
  • 主要企业的招聘策略
  • 关键成功策略
  • 近期市场活动
  • 主要企业市场占有率
• 主要企业简介
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • SK chemicals
  • Green Cross Corp
  • Geneone Life Science
  • Vaccitech
  • CanSinoBIO

Global Shingles Vaccine Market size was valued at USD 3.5 Billion in 2021 and is poised to grow from USD 3.99 Billion in 2022 to USD 11.29 Billion by 2030, growing at a CAGR of 7.6% in the forecast period (2023-2030).

The Global Shingles Vaccine Market is poised for robust growth in the coming years, driven by a combination of factors including an aging population, increasing awareness about the vaccine's effectiveness in preventing shingles and related complications, and expanding vaccination programs in various regions. The market is witnessing a steady rise in demand for both live attenuated and recombinant subunit shingles vaccines, with the latter gaining traction due to its safety profile. Furthermore, ongoing research and development efforts to improve vaccine efficacy and accessibility, coupled with government initiatives to promote adult vaccination, are anticipated to fuel market expansion. Key players in the pharmaceutical industry are expected to focus on innovation and strategic collaborations to capitalize on this growing market opportunity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Shingles Vaccine Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The shingles vaccine market is segmented based on Product, Vaccine Type, and Regional. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future. Based on Product the market is segmented as, Shingrix, Zostavax, SKYZoster. Based on Vaccine Type the market is segmented as, Recombinant Vaccine, Live Attenuated Vaccine. Based on Regional the market is segmented as, North America, Asia Pacific, Latin America, Middle East & Africa (MEA).

Driver:

The Global Shingles Vaccine Market is experiencing significant growth driven by several key factors. Firstly, an aging population worldwide has led to a higher susceptibility to shingles, creating a robust demand for preventive vaccines. Additionally, rising awareness about the importance of vaccination and the efficacy of shingles vaccines in reducing the severity and incidence of the disease is fueling market expansion. Furthermore, government initiatives and healthcare policies aimed at promoting adult immunization are bolstering market adoption. The introduction of innovative vaccines, such as recombinant subunit vaccines, is also contributing to market growth by offering improved efficacy and reduced side effects. Overall, the Global Shingles Vaccine Market is poised for continued expansion as the global healthcare community prioritizes prevention and immunization against shingles.

Restraint:

The Global Shingles Vaccine Market is currently experiencing several restraints that are impacting its growth trajectory. Firstly, the high cost of shingles vaccines has limited accessibility for a significant portion of the population, particularly in low- and middle-income countries, thus impeding market expansion. Secondly, the limited awareness about the severity of shingles and the benefits of vaccination among the general public is hindering the market's potential. Additionally, logistical challenges in vaccine distribution and storage, especially in remote areas, pose a significant barrier to market penetration. Lastly, regulatory hurdles and the lack of reimbursement policies in some regions are inhibiting market growth, making it crucial for stakeholders to address these constraints to unlock the full potential of the global shingles vaccine market.

Market Trends:

One key market trend in the Global Shingles Vaccine Market is the growing emphasis on preventive healthcare and immunization programs among aging populations. As the world's elderly population continues to expand, there is an increasing awareness of the importance of shingles vaccination in reducing the risk of this painful and debilitating condition. Governments and healthcare organizations are actively promoting shingles vaccination campaigns, leading to rising vaccine adoption rates. Additionally, advancements in vaccine technology, such as the development of more effective and longer-lasting vaccines, are anticipated to further drive market growth. Overall, the Global Shingles Vaccine Market is poised for significant expansion as a result of these demographic and technological factors.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Shingles Vaccine Market by Product
  • Market Overview
  • Shingrix
  • Zostavax
  • and SKYZoster
• Global Shingles Vaccine Market by Vaccine Type
  • Market Overview
  • Recombinant Vaccine
  • and Live Attenuated Vaccine
• Global Shingles Vaccine Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • GlaxoSmithKline plc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Merck & Co., Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • SK chemicals
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Green Cross Corp
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Geneone Life Science
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Vaccitech
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • CanSinoBIO
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments